Cardiff Oncology, Inc. Quarterly Debt-to-equity in % from Q3 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cardiff Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q2 2024.
  • Cardiff Oncology, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 18.9 %, a 84.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 18.9 +8.68 +84.9% Jun 30, 2024
Q1 2024 15.8 +6.36 +67.6% Mar 31, 2024
Q4 2023 13.1 +4.6 +53.9% Dec 31, 2023
Q3 2023 11.3 +3.45 +44.1% Sep 30, 2023
Q2 2023 10.2 +3.22 +45.9% Jun 30, 2023
Q1 2023 9.42 +3.74 +65.9% Mar 31, 2023
Q4 2022 8.54 +3.62 +73.5% Dec 31, 2022
Q3 2022 7.82 +3.27 +71.9% Sep 30, 2022
Q2 2022 7.01 +1.83 +35.3% Jun 30, 2022
Q1 2022 5.67 -1.72 -23.3% Mar 31, 2022
Q4 2021 4.92 -7.52 -60.4% Dec 31, 2021
Q3 2021 4.55 -27.9 -86% Sep 30, 2021
Q2 2021 5.19 -45.3 -89.7% Jun 30, 2021
Q1 2021 7.4 -67.7 -90.1% Mar 31, 2021
Q4 2020 12.4 -51.9 -80.7% Dec 31, 2020
Q3 2020 32.4 -22.1 -40.5% Sep 30, 2020
Q2 2020 50.5 +8.47 +20.2% Jun 30, 2020
Q1 2020 75.1 +41.5 +124% Mar 31, 2020
Q4 2019 64.3 +25.3 +64.7% Dec 31, 2019
Q3 2019 54.5 +8.2 +17.7% Sep 30, 2019
Q2 2019 42 -31.8 -43.1% Jun 30, 2019
Q1 2019 33.5 -121 -78.3% Mar 31, 2019
Q4 2018 39.1 -149 -79.2% Dec 31, 2018
Q3 2018 46.3 -125 -72.9% Sep 30, 2018
Q2 2018 73.8 -62.4 -45.8% Jun 30, 2018
Q1 2018 155 +45.8 +42% Mar 31, 2018
Q4 2017 188 +105 +128% Dec 31, 2017
Q3 2017 171 +105 +160% Sep 30, 2017
Q2 2017 136 +83.2 +157% Jun 30, 2017
Q1 2017 109 +50.4 +86.2% Mar 31, 2017
Q4 2016 82.7 +18.8 +29.5% Dec 31, 2016
Q3 2016 65.7 -20.6 -23.9% Sep 30, 2016
Q2 2016 53 -89.3 -62.8% Jun 30, 2016
Q1 2016 58.5 -74.8 -56.1% Mar 31, 2016
Q4 2015 63.8 -55.4 -46.5% Dec 31, 2015
Q3 2015 86.3 +8.53 +11% Sep 30, 2015
Q2 2015 142 +89.6 +170% Jun 30, 2015
Q1 2015 133 +74.2 +125% Mar 31, 2015
Q4 2014 119 +31.7 +36.2% Dec 31, 2014
Q3 2014 77.8 -93.3 -54.5% Sep 30, 2014
Q2 2014 52.7 -493 -90.3% Jun 30, 2014
Q1 2014 59.1 -126 -68.1% Mar 31, 2014
Q4 2013 87.5 -190 -68.5% Dec 31, 2013
Q3 2013 171 -821 -82.8% Sep 30, 2013
Q2 2013 545 Jun 30, 2013
Q1 2013 185 Mar 31, 2013
Q4 2012 278 Dec 31, 2012
Q3 2012 992 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.